PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-11.20%
Negative revenue growth while OBE stands at 17.31%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-18.65%
Negative gross profit growth while OBE is at 214.46%. Joel Greenblatt would examine cost competitiveness or demand decline.
-21.71%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-21.71%
Negative operating income growth while OBE is at 235.37%. Joel Greenblatt would press for urgent turnaround measures.
-60.51%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-60.19%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-60.13%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.95%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.13%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
3.19%
Dividend growth of 3.19% while OBE is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-49.79%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-90.09%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-27.22%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
83.80%
5Y revenue/share CAGR 1.25-1.5x OBE's 66.98%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
31.49%
3Y revenue/share CAGR under 50% of OBE's 80.24%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-61.60%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
12.84%
Below 50% of OBE's 5605.50%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-23.15%
Negative 3Y OCF/share CAGR while OBE stands at 98.63%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
60.11%
Net income/share CAGR at 50-75% of OBE's 111.23%. Martin Whitman might question if the firm’s product or cost base lags behind.
224.97%
5Y net income/share CAGR above 1.5x OBE's 120.67%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
5.49%
Positive short-term CAGR while OBE is negative. John Neff would see a clear advantage in near-term profit trajectory.
7.74%
Positive growth while OBE is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
-10.27%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
139.40%
Below 50% of OBE's 351.47%. Michael Burry suspects a serious short-term disadvantage in building book value.
-13.80%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
158.81%
Dividend/share CAGR of 158.81% while OBE is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
221.47%
3Y dividend/share CAGR of 221.47% while OBE is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-3.27%
Firm’s AR is declining while OBE shows 18.86%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
-0.77%
Negative asset growth while OBE invests at 2.89%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.09%
We have a declining book value while OBE shows 0.96%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
6.42%
Debt shrinking faster vs. OBE's 25.09%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
2.27%
SG&A declining or stable vs. OBE's 972.00%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.